This Article Full Text Full Text (PDF) All Versions of this Article: 92/8/3202    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kluge, M. Articles by Steiger, A. Search for Related Content PubMed PubMed Citation Articles by Kluge, M. Articles by Steiger, A. Related Collections Male Endocrinology Neuroendocrinology and Pituitary

Ghrelin Suppresses Secretion of Luteinizing Hormone in Humans

Max-Planck Institute of Psychiatry, 80804 Munich, Germany

Address all correspondence and requests for reprints to: Dr. Michael Kluge, Max-Planck Institute of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany. E-mail: kluge{at}mpipsykl.mpg.de.

Context: Ghrelin affects the hypothalamic-pituitary-gonadal axis in various nonhuman mammalians, predominantly by suppressing secretion of LH. However, for humans, no such evidence exists.

Objective: Our objective was to study the effect of ghrelin on secretion of LH and testosterone in humans.

Design, Participants, and Intervention: Nocturnal (2000–0700 h) secretion profiles of LH and testosterone were determined in 10 healthy males (25.7 ± 3.0 yr) twice, receiving 50 µg ghrelin or placebo at 2200, 2300, 2400, and 0100 h, in this single-blind, randomized, cross-over study.

Results: Ghrelin was associated with significantly (P < 0.05) lower mean plasma levels of both LH (2340–0200 h) and testosterone (0040–0300 h) than placebo. LH peak levels of the pulse after first administration of ghrelin/placebo were significantly (P = 0.014) smaller in the ghrelin (2.98 ± 1.34 mIU/ml) than in the placebo condition (4.37 ± 1.09 mIU/ml). In addition, the interval between this and the preceding peak was significantly (P = 0.010) longer in the ghrelin (255.8 ± 79.1 min) than in the placebo condition (190.8 ± 51.0 min). Significantly (P = 0.005) more LH pulses occurred with placebo (3.2 ± 0.75) than ghrelin (2.6 ± 0.7) subsequent to ghrelin/placebo administration.

Conclusions: Ghrelin caused both a delay and suppression of the amplitude of LH pulses. These findings are in accordance with those in nonhuman mammalians.

This article has been cited by other articles:

				I. Viani, A. Vottero, F. Tassi, G. Cremonini, C. Sartori, S. Bernasconi, B. Ferrari, and L. Ghizzoni Ghrelin Inhibits Steroid Biosynthesis by Cultured Granulosa-Lutein Cells J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1476 - 1481. [Abstract] [Full Text] [PDF]

				N. R Vulliemoz, E. Xiao, L. Xia-Zhang, J. Rivier, and M. Ferin Astressin B, a Nonselective Corticotropin-Releasing Hormone Receptor Antagonist, Prevents the Inhibitory Effect of Ghrelin on Luteinizing Hormone Pulse Frequency in the Ovariectomized Rhesus Monkey Endocrinology, March 1, 2008; 149(3): 869 - 874. [Abstract] [Full Text] [PDF]